Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | MYO1E |
| Upstream (Parents) |
|---|
| (<<) ADCY7 → MYO1E |
| (<<) BBS1 → MYO1E |
| (<<) CCND3 → MYO1E |
| (<<) CDH3 → MYO1E |
| (<<) CISH → MYO1E |
| (<<) CSGALNACT2 → MYO1E |
| (<<) CSNK1D → MYO1E |
| (<<) E2F3 → MYO1E |
| (<<) EGFR → MYO1E |
| (<<) GLS → MYO1E |
| (<<) GPNMB → MYO1E |
| (<<) ICAM2 → MYO1E |
| (<<) IGFBP3 → MYO1E |
| (<<) ITGA6 → MYO1E |
| (<<) KHDRBS3 → MYO1E |
| (<<) KLF6 → MYO1E |
| (<<) LPIN1 → MYO1E |
| (<<) MAP3K6 → MYO1E |
| (<<) MSN → MYO1E |
| (<<) NFIB → MYO1E |
| (<<) NRSN2 → MYO1E |
| (<<) NXT1 → MYO1E |
| (<<) PLOD2 → MYO1E |
| (<<) PRKX → MYO1E |
| (<<) RBM7 → MYO1E |
| (<<) RNF138 → MYO1E |
| (<<) SALL2 → MYO1E |
| (<<) SCG5 → MYO1E |
| (<<) SGK1 → MYO1E |
| (<<) SLC7A5 → MYO1E |
| (<<) ST3GAL6 → MYO1E |
| (<<) STC2 → MYO1E |
| (<<) TMEM158 → MYO1E |
| (<<) TMSB10 → MYO1E |
| (<<) TPM4 → MYO1E |
| Downstream (Children) |
|---|
| MYO1E → AKT3 (>>) |
| MYO1E → ATP10B (>>) |
| MYO1E → BCL2 (>>) |
| MYO1E → COL13A1 (>>) |
| MYO1E → CRK (>>) |
| MYO1E → EFNB2 (>>) |
| MYO1E → FZD5 (>>) |
| MYO1E → HCN4 (>>) |
| MYO1E → ITGAE (>>) |
| MYO1E → KRAS (>>) |
| MYO1E → MAP3K4 (>>) |
| MYO1E → MMP1 (>>) |
| MYO1E → PGF (>>) |
| MYO1E → SMARCC2 (>>) |
| MYO1E → SPRY2 (>>) |
| MYO1E → STX12 (>>) |
| MYO1E → TSPO (>>) |
| MYO1E → ZNF224 (>>) |
